HUMERA KHATOON et al. HARNESSING CRISPR-CAS TECHNOLOGIES FOR PAEDIATRIC IMMUNODEFICIENCIES: A NEW FRONTIER. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 4, p. 64–78, 2024. DOI: 10.53555/jptcp.v31i4.5157. Disponível em: https://jptcp.com/index.php/jptcp/article/view/5157. Acesso em: 16 sep. 2026.